170 related articles for article (PubMed ID: 20843686)
1. Design and optimization of new piperidines as renin inhibitors.
Corminboeuf O; Bezençon O; Grisostomi C; Remeň L; Richard-Bildstein S; Bur D; Prade L; Hess P; Strickner P; Fischli W; Steiner B; Treiber A
Bioorg Med Chem Lett; 2010 Nov; 20(21):6286-90. PubMed ID: 20843686
[TBL] [Abstract][Full Text] [Related]
2. Piperidine-based renin inhibitors: upper chain optimization.
Corminboeuf O; Bezençon O; Remeň L; Grisostomi C; Richard-Bildstein S; Bur D; Prade L; Strickner P; Hess P; Fischli W; Steiner B; Treiber A
Bioorg Med Chem Lett; 2010 Nov; 20(21):6291-6. PubMed ID: 20843690
[TBL] [Abstract][Full Text] [Related]
3. Optimization of orally bioavailable alkyl amine renin inhibitors.
Xu Z; Cacatian S; Yuan J; Simpson RD; Jia L; Zhao W; Tice CM; Flaherty PT; Guo J; Ishchenko A; Singh SB; Wu Z; McKeever BM; Scott BB; Bukhtiyarov Y; Berbaum J; Mason J; Panemangalore R; Cappiello MG; Bentley R; Doe CP; Harrison RK; McGeehan GM; Dillard LW; Baldwin JJ; Claremon DA
Bioorg Med Chem Lett; 2010 Jan; 20(2):694-9. PubMed ID: 19959358
[TBL] [Abstract][Full Text] [Related]
4. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines.
Chen A; Campeau LC; Cauchon E; Chefson A; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Grimm E; Han Y; Houle R; Huang JQ; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; McKay D; Percival MD; Regan C; Regan H; St-Jacques R; Toulmond S
Bioorg Med Chem Lett; 2011 Jul; 21(13):3970-5. PubMed ID: 21621998
[TBL] [Abstract][Full Text] [Related]
5. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of tertiary alcohol-bearing piperidines.
Chen A; Cauchon E; Chefson A; Dolman S; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Gallant M; Grimm E; Han Y; Houle R; Huang JQ; Hughes G; Jûteau H; Lacombe P; Lauzon S; Lévesque JF; Liu S; Macdonald D; Mackay B; McKay D; Percival MD; St-Jacques R; Toulmond S
Bioorg Med Chem Lett; 2011 Jul; 21(13):3976-81. PubMed ID: 21641209
[TBL] [Abstract][Full Text] [Related]
6. 3,4-Diarylpiperidines as potent renin inhibitors.
Lacombe P; Arbour M; Aspiotis R; Cauchon E; Chen A; Dubé D; Falgueyret JP; Fournier PA; Gallant M; Grimm E; Han Y; Juteau H; Liu S; Mellon C; Ramtohul Y; Simard D; St-Jacques R; Tsui GC
Bioorg Med Chem Lett; 2012 Mar; 22(5):1953-7. PubMed ID: 22325946
[TBL] [Abstract][Full Text] [Related]
7. Design and optimization of a substituted amino propanamide series of renin inhibitors for the treatment of hypertension.
Chen A; Bayly C; Bezençon O; Richard-Bildstein S; Dubé D; Dubé L; Gagné S; Gallant M; Gaudreault M; Grimm E; Houle R; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; Martin D; McKay D; Powell D; Remen L; Soisson S; Toulmond S
Bioorg Med Chem Lett; 2010 Apr; 20(7):2204-9. PubMed ID: 20206513
[TBL] [Abstract][Full Text] [Related]
8. The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors.
Cody WL; Holsworth DD; Powell NA; Jalaie M; Zhang E; Wang W; Samas B; Bryant J; Ostroski R; Ryan MJ; Edmunds JJ
Bioorg Med Chem; 2005 Jan; 13(1):59-68. PubMed ID: 15582452
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors.
Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Fujimoto T; Sugita C; Miyazaki S; Tamaki K; Nagayama T; Nagai Y; Inoue S; Chiba K; Nishi T
Bioorg Med Chem; 2013 Sep; 21(18):5907-22. PubMed ID: 23886807
[TBL] [Abstract][Full Text] [Related]
10. A novel class of oral direct renin inhibitors: highly potent 3,5-disubstituted piperidines bearing a tricyclic p3-p1 pharmacophore.
Ostermann N; Ruedisser S; Ehrhardt C; Breitenstein W; Marzinzik A; Jacoby E; Vangrevelinghe E; Ottl J; Klumpp M; Hartwieg JC; Cumin F; Hassiepen U; Trappe J; Sedrani R; Geisse S; Gerhartz B; Richert P; Francotte E; Wagner T; Krömer M; Kosaka T; Webb RL; Rigel DF; Maibaum J; Baeschlin DK
J Med Chem; 2013 Mar; 56(6):2196-206. PubMed ID: 23360239
[TBL] [Abstract][Full Text] [Related]
11. Design and discovery of new (3S,5R)-5-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]piperidine-3-carboxamides as potent renin inhibitors.
Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Sugita C; Miyazaki S; Tamaki K; Matsui Y; Takahashi M; Nagayama T; Nagai Y; Inoue S; Nishi T
Bioorg Med Chem Lett; 2012 Dec; 22(24):7677-82. PubMed ID: 23122821
[TBL] [Abstract][Full Text] [Related]
12. Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors.
Bezençon O; Bur D; Weller T; Richard-Bildstein S; Remen L; Sifferlen T; Corminboeuf O; Grisostomi C; Boss C; Prade L; Delahaye S; Treiber A; Strickner P; Binkert C; Hess P; Steiner B; Fischli W
J Med Chem; 2009 Jun; 52(12):3689-702. PubMed ID: 19358611
[TBL] [Abstract][Full Text] [Related]
13. Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors.
Scheiper B; Matter H; Steinhagen H; Stilz U; Böcskei Z; Fleury V; McCort G
Bioorg Med Chem Lett; 2010 Nov; 20(21):6268-72. PubMed ID: 20850300
[TBL] [Abstract][Full Text] [Related]
14. Biphenyl/diphenyl ether renin inhibitors: filling the S1 pocket of renin via the S3 pocket.
Yuan J; Simpson RD; Zhao W; Tice CM; Xu Z; Cacatian S; Jia L; Flaherty PT; Guo J; Ishchenko A; Wu Z; McKeever BM; Scott BB; Bukhtiyarov Y; Berbaum J; Panemangalore R; Bentley R; Doe CP; Harrison RK; McGeehan GM; Singh SB; Dillard LW; Baldwin JJ; Claremon DA
Bioorg Med Chem Lett; 2011 Aug; 21(16):4836-43. PubMed ID: 21741239
[TBL] [Abstract][Full Text] [Related]
15. Design and optimization of renin inhibitors: Orally bioavailable alkyl amines.
Tice CM; Xu Z; Yuan J; Simpson RD; Cacatian ST; Flaherty PT; Zhao W; Guo J; Ishchenko A; Singh SB; Wu Z; Scott BB; Bukhtiyarov Y; Berbaum J; Mason J; Panemangalore R; Cappiello MG; Müller D; Harrison RK; McGeehan GM; Dillard LW; Baldwin JJ; Claremon DA
Bioorg Med Chem Lett; 2009 Jul; 19(13):3541-5. PubMed ID: 19457666
[TBL] [Abstract][Full Text] [Related]
16. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of spirocyclic piperidines.
Chen A; Aspiotis R; Campeau LC; Cauchon E; Chefson A; Ducharme Y; Falgueyret JP; Gagné S; Han Y; Houle R; Laliberté S; Larouche G; Lévesque JF; McKay D; Percival D
Bioorg Med Chem Lett; 2011 Dec; 21(24):7399-404. PubMed ID: 22071301
[TBL] [Abstract][Full Text] [Related]
17. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors.
Xin Z; Zhao H; Serby MD; Liu B; Liu M; Szczepankiewicz BG; Nelson LT; Smith HT; Suhar TS; Janis RS; Cao N; Camp HS; Collins CA; Sham HL; Surowy TK; Liu G
Bioorg Med Chem Lett; 2008 Aug; 18(15):4298-302. PubMed ID: 18632269
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
[TBL] [Abstract][Full Text] [Related]
19. Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.
Andrews DM; Stokes ES; Carr GR; Matusiak ZS; Roberts CA; Waring MJ; Brady MC; Chresta CM; East SJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2580-4. PubMed ID: 18378449
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel non-peptidic ketopiperazine-based renin inhibitors.
Holsworth DD; Powell NA; Downing DM; Cai C; Cody WL; Ryan JM; Ostroski R; Jalaie M; Bryant JW; Edmunds JJ
Bioorg Med Chem; 2005 Apr; 13(7):2657-64. PubMed ID: 15755665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]